UBS raised the firm’s price target on IBM (IBM) to $210 from $200 and keeps a Sell rating on the shares. The firm, which raised its price target as it rolls its valuation basis to calendar year 2027, argues that “key metrics flash caution” into 2026 and that it is “not too early to focus on the puts and takes heading into” the outlook for next year as Red Hat and TP constant currency growth “disappoint” in Q3.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBM:
- IBM price target raised to $305 from $300 at BMO Capital
- Will Microsoft Stock Outshine IBM after Big Blue’s Blowout Earnings?
- Cautious Outlook on IBM: Hold Rating Amid Software Segment Challenges and Valuation Concerns
- IBM price target lowered to $295 from $310 at Stifel
- IBM price target raised to $315 from $310 at BofA